New York Times The authors intended audience are
patients who looking for medical care. To inform them that's doctors are being
penalized or rewarded for the treatments that provide. And those insurers are
the reason for this corruption that is accruing in the medical field. This
article was written By Pamela Hartzband and Jerome Groopman. They are both
respected
M.D; Pamela Hartzband is an Assistant Professor at Harvard
medical school and Jerome E. Groopman has been a staff writer in medicine and
biology for The New Yorker since 1998. He is also the Dina and Raphael Chair of
Medicine at Harvard Medical School. They are both credible authors. They claim
that medical care is bringing corrupted by insures who penalize or reward
doctors for certain treatment plans.
This article shows there point through
information given by company's "WellPoint, one of the largest private
payers for health care, recently outlined designated treatment pathways for
cancer and announced that it would pay physicians an incentive of $350 per
month per patient treated on the designated pathway." the belief is that
physician Will cause moral licensing” — the physician is able to rationalize
forcing or withholding treatment, regardless of clinical judgment or patient
preference, as acceptable for the good of the population." I agree with
opinion because the information gives no information about people suffering
from this but only gives the potential causes for concern I find it hard to
take this topic as serious as they have presented it. Congress has also made
steps to rectify this situation so in my opinion this is not a strong argument
for this issue.
No comments:
Post a Comment